CSL:ASX
CSL Ltd
A$194.05
arrow_upward
+0.96%(+1.85) 1D
Oct 19, 4:10:09 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$193.90
High
A$194.90
Low
A$192.74
Mkt. cap
93.12B
Avg. vol.
1.13M
Volume
941.25K
Dividend
1.46%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$221.76
52-wk low
A$90.00
EPS
-A$7.73
Shares outstanding
479.88M
No. of employees
29K
Open
A$193.90
High
A$194.90
Low
A$192.74
Mkt. cap
93.12B
Avg. vol.
1.13M
Volume
941.25K
Dividend
1.46%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$221.76
52-wk low
A$90.00
EPS
-A$7.73
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
ad-hoc-news.de
·
50 minutes ago
CSL stock: CSL annual meeting is set for October 27, 2026
ad-hoc-news.de
·
7 hours ago
Morgan Stanley sets AUD 200.00 target for CSL stock
ad-hoc-news.de
·
9 hours ago
CSL stock: Sydney gains 0.96 percent ahead of the Xetra open
Kalkine Media
·
13 hours ago
What Is Driving CSL Shares after its Reset Year (ASX:CSL)?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com